Phospholipase C-β3 is dispensable for vascular constriction but indispensable for vascular hyperplasia.
Saved in:
| Title: | Phospholipase C-β3 is dispensable for vascular constriction but indispensable for vascular hyperplasia. |
|---|---|
| Authors: | Jin SY; Medical Research Institute, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea., Ha JM; Medical Research Institute, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea., Kum HJ; Medical Research Institute, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea., Ma JS; Department of Immunoparasitology, Osaka University, Suita, Japan., Ha HK; Department of Urology, Pusan National University Hospital, Busan, Republic of Korea., Song SH; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea., Yang YR; Aging Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea., Lee H; Carcinogenesis and Metastasis Research Branch, National Cancer Center, Goyang, Republic of Korea., Bae YS; Department of Life Science, Ewha Womans University, Seoul, Republic of Korea., Yamamoto M; Department of Immunoparasitology, Osaka University, Suita, Japan., Suh PG; Korea Brain Research Institute, Daegu, Republic of Korea., Bae SS; Medical Research Institute, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea. sunsik@pusan.ac.kr. |
| Source: | Experimental & molecular medicine [Exp Mol Med] 2024 Jul; Vol. 56 (7), pp. 1620-1630. Date of Electronic Publication: 2024 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
